Gilead Sciences (GILD) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY25 Guidance
Go back to Gilead Sciences (GILD) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY25 Guidance| Gilead Sciences (NASDAQ: GILD) | Delayed: 129.61 -1.66 (1.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.27 | 52 Week High | $108.63 | |||
| Open | $132.88 | 52 Week Low | $71.39 | |||
| Day High | $132.88 | P/E | 71.61 | |||
| Day Low | $127.88 | EPS | $1.81 | |||
| Volume | 9,789,694 | |||||

